Biogen is teaming with Happify on an AI-driven app platform and a digital platform to help MS patients (Happify Health)
July 5, 2022 01:56 PM EDT
Pharma
Marketing

Bio­gen leans in­to dig­i­tal ther­a­peu­tics for mul­ti­ple scle­ro­sis, teams with Hap­pi­fy Health

Beth Snyder Bulik

Senior Editor

Bio­gen is look­ing out­side its walls for dig­i­tal so­lu­tions to help mul­ti­ple scle­ro­sis pa­tients. Its new part­ner­ship with Hap­pi­fy Health on an MS dig­i­tal ther­a­peu­tic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times